Atrial fibrillation (AF) is a potent risk factor for CES, conferring a 5-fold higher risk for stroke among affected individuals, and its prevalence in the United States is expected to rise to 12 million in 2050. 4, 8 Large registries and trials have shown that AF-related strokes constitute the most severe ischemic stroke subtype. 3, 5, 6, 9 Yet, the majority of studies compared patients with AF-related strokes with patients with strokes deemed unrelated to cardioembolic sources, that is, those with small-or large-vessel disease-related strokes. 5, 6, 9 An important remaining question is whether the risk of a unfavorable poststroke outcome after CES differs based on the underlying pathomechanism. Specifically, do patients with AF-related CES have a greater ischemic stroke severity and worse outcomes than patients with non-AF-related CES? Clarifying this issue will aid to better define the pathophysiological link between AF and ischemic stroke and has the potential to enhance stroke treatment.
D
espite substantial progress in recognition and acute therapy, ischemic stroke remains a leading cause of disability and death worldwide and accounts for ≈130 000 deaths in the United States annually. 1 Outcomes and recommended therapeutic interventions differ according to the underlying stroke mechanism. 2, 3 Specifically, cardioembolic stroke (CES), accounting for ≈1 in 5 ischemic strokes, exerts a profound societal effect, association with greater disability, higher mortality rates, and higher treatment costs when compared with patients with strokes from other causes. [4] [5] [6] [7] Moreover, the prevalence of CES is increasing among the elderly, a growing population at the highest risk of incident stroke. 90 days post stroke in a contemporary cohort of patients with CES mechanism admitted to the University of Massachusetts Medical Center between 2011 and 2014. We specifically hypothesized that patients with AF-related CES have worse outcomes than patients with non-AF-related CES.
Methods

Study Cohort
We retrospectively analyzed patients with acute hemispheric ischemic stroke as shown on brain magnetic resonance imaging (MRI) and included in the University of Massachusetts Medical Center Stroke registry between March 2010 and March 2014. Of note, included patients have been described as part of previously published studies. 10, 11 We restricted analyses to patients with brain MRI to reliably determine the infarct extent and to exclude stroke mimics. Furthermore, we excluded patients with infratentorial infarct location from the present analyses because both prevalence of AF and outcome predicting variables differ from supratentorial strokes. 12, 13 Our investigation was approved by our Institutional Review Board (number, H00006964) and Health Insurance Portability and Accountability Act waiver of informed consent granted. We adhere to the Strengthening the Reporting of Observational studies in Epidemiology guidelines (http://www.strobe-statement.org).
Stroke Cause and Severity
Patient demographics, laboratory data, comorbidities, preadmission medications, and stroke cause (using the Causative Classification System for ischemic stroke 14 ) based on diagnostic evaluation were collected on all patients. Briefly, the Causative Classification System is a free web-based, semiautomated, evidence-based classification system. Its decision-making algorithm assigns the most likely causative mechanism in a rule-based manner to 5 major categories (based on the Trial of ORG-10172 in Acute Stroke Treatment classification) with additional subdivision according to the weight of evidence (evident, probable, and possible) of an assignment (http://ccs.mgh.harvard.edu). 14 Members of the stroke team certified in National Institutes of Health Stroke Scale (NIHSS) scoring graded the severity of stroke at presentation. The modified Rankin Scale (mRS) was assessed at discharge and 90 days after admission by a stroke-trained physician or stroke study nurse certified in mRS via in-person interview. 10, 15 When the mRS was unavailable, the same observers reconstructed the score from the case description according to the mRS criteria. 15 The 90-day outcome was dichotomized into favorable (mRS score, 0-1) versus unfavorable (mRS score, 2-6).
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Study Participants
We identified 316 patients with a diagnosis of acute hemispheric ischemic stroke and MRI brain imaging. Figure 1 summarizes the flow of patient exclusion. For the primary analyses, we excluded patients who had no CES mechanism (n=132), patients in whom the infarct cause could be attributed to either a CES or a competing non-CES mechanism (eg, concurrent ipsilesional high-grade carotid artery stenosis and AF, n=23), and patients who had an embolic stroke of undetermined source (n=21). Three patients had a recurrent stroke during the first 90 day and were excluded. Data were complete in 140 included patients for all variables except for the low-density lipoprotein cholesterol (n=2 missing).
Risk Factor Definitions
We determined the presence of hypertension (use of antihypertensive medications or systolic blood pressure of ≥140 mm Hg or diastolic blood pressure of ≥90 mm Hg on 2 separate occasions), hypercholesterolemia (use of lipid-lowering agents or fasting blood total cholesterol level of ≥200 mg/dL or low-density lipoprotein cholesterol of ≥130 mg/dL), and diabetes mellitus (defined according to the National Diabetes Data Group and World Health Organization 17 ). 
Diagnosis of AF
AF was defined according to the American Heart Association guidelines. 4 Diagnosis of prevalent AF was determined based on history (documented AF on preadmission ECG or history of oral anticoagulation for AF). Incident AF was defined as newly diagnosed AF during hospitalization or AF diagnosed between the index hospitalization and 90-day follow-up. AF was confirmed by the absence of distinct P waves (showing replacement of consistent P waves by rapid oscillations of fibrillatory waves that vary in size, shape, and timing) with an irregular ventricular response on a standard 12-lead electrocardiography, 30-day event monitoring, implantable loop recorder, and pacemaker data, as well as clinical follow-up notes for documentation of incident AF. 18 For statistical purposes, we dichotomized AF to absent versus present (combined prevalent and incident).
Neuroimaging Protocol
Brain MRI included T1-, T2-, and fluid-attenuated inversion recovery sequences, as well as diffusion-weighted images (DWI) obtained on a 1.5-Tesla scanner (GE Signa; GE Medical Systems, Milwaukee, WI) as previously detailed. 10 In brief, DWI was obtained using echo planar imaging with a repetition time of 8000 ms, an echo time of 102 ms, a field of view of 22×22 cm, image matrix of 128×128, slice thickness of 5 mm with a 1-mm gap, and β values of 0 and 1000 s/mm 2 . Fluidattenuated inversion recovery was obtained with a repetition time of 9002 ms, an echo time of 143 ms, a field of view of 22×22 cm, image matrix of 256×224, and slice thickness of 6 mm with a 1-mm gap. All images were evaluated by a neuroradiologist to confirm the presence of acute ischemic infarction.
Infarct Volume Assessment
DWI sequences were reviewed independently by experienced readers (N.H. and J.H.) who were blinded to clinical data and follow-up scans. Lesions that were hyperintense on DWI and hypointense or isointense on the apparent diffusion coefficient maps were considered acute ischemic infarcts. 10 Ischemic infarcts on DWI were manually outlined using careful windowing to achieve the maximal visual extent of the acute DWI (b1000 trace weighted) infarct and with reference to the apparent diffusion coefficient image to avoid regions of T2 shine through.
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Statistics
Unless otherwise stated, continuous variables are reported as mean±SD or median (25th to 75th quartile). Categorical variables are reported as proportions. Normality of data was examined using Shapiro-Wilk test. Between-group comparisons for continuous and ordinal variables were made with Mann-Whitney U test and KruskalWallis 1-way ANOVA by ranks as appropriate. Categorical variables were compared using the χ 2 test or Fisher exact test. Ninety-day survival was compared by Kaplan-Meier curves and the Log-rank test.
We first constructed a multivariable binary logistic regression model to determine factors that were independently associated with AF (adjusted for age, sex, vascular disease, congestive heart failure, diabetes mellitus, history of ischemic stroke/TIA, and admission NIHSS).
To determine whether the presence of AF was independently associated with an unfavorable poststroke outcome at 90 days, we constructed a multivariable logistic regression model adjusted for the CHA 2 DS 2 -VASc score, infarct volume, preadmission mRS, and admission NIHSS.
To avoid model overfitting, a backward elimination method (likelihood ratio) was used for all models. Collinearity diagnostics were performed (and its presence rejected) for all multivariable regression models. The Hosmer-Lemeshow goodness-of-fit statistic was used to assess model fit. Two-sided significance tests were used throughout, and unless stated otherwise, a 2-sided P<0.05 was considered statistically significant. All statistical analyses were performed using IBM SPSS Statistics Version 22 (IBM, Armonk, NY).
Results
Patient Population
Baseline characteristics of included patients stratified by the 90-day outcome are summarized in Table 1 . Table I in the onlineonly Data Supplement summarizes the baseline characteristics of included patients (n=140) versus excluded patients who did not have a CES mechanism (n=176). Of note, among patients with a TIA as the exclusion criterion (n=104), the presumed TIA mechanism was related to large-artery disease in 16 
Factors Associated With AF Among Patients With CES
Among included patients, 97 had an evident and 43 had a probable/possible CES mechanism (Figure 1 ). Table II in the online-only Data Supplement indicates possible cardiac thromboembolic sources (except AF) for included patients.
Overall, 80 patients had prevalent (n=52) or incident (n=28) AF. Patients with AF (prevalent and incident combined) were on average older (76±11 versus 65±18 years; P<0.001), more likely to be women (60% versus 40%; P=0.026), more likely to be treated with an anticoagulant before presentation (19% versus 2%; P=0.001), and less likely to have a history of vascular disease (20% versus 37%; P=0.035) when compared with patients who were not diagnosed with AF. In addition, patients with AF had a higher admission NIHSS (11±8 versus 7±6 points; P=0.004; Figure 2A ), a greater baseline CHA 2 DS 2 -VASc score (4 [3] [4] [5] Figure 2C ) when compared with patients without AF. To account for preadmission functional deficits, we also calculated the worsening of the mRS score from baseline to Figure 2C ). There was no difference in the 90-day survival between patients with versus without AF (P=0.226; Figure 2D ). Baseline characteristics of included patients further stratified by AF status (trichotomized to no AF, prevalent AF, and newly diagnosed AF) are summarized in Table III in the online-only Data Supplement.
After adjustment for potential confounders, older age (P=0.001), higher admission NIHSS (P=0.008), and absent vascular disease (0.016) were independently associated with AF (Table IV in the online-only Data Supplement). Entering the CHA 2 DS 2 -VASc score instead of its individual components indicated that only an older age (P<0.001) and higher admission NIHSS score (P=0.005) were independently associated with a diagnosis with AF (Table V in the online-only Data Supplement). Data are presented as n (%) or median (25th to 75th quartile). CES indicates cardioembolic stroke; CHA 2 DS 2 -VASc, congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, previous stroke/TIA (doubled), vascular disease, age 65-74 years, sex category (female); LDL, low-density lipoprotein cholesterol; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; r-tPA, recombinant tissue-type plasminogen activator; and TIA, transient ischemic attack.
*With or without intravenous r-tPA.
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In unadjusted analyses, older age, greater infarct volume, the presence of AF, previous stroke/TIA, as well as higher baseline CHA 2 DS 2 -VASc-score, worse admission NIHSS score, and greater preadmission mRS score were related to an unfavorable 90-day functional status (Table 1 ). Figure 2 depicts the distribution of 90-day mRS score as stratified by the absence versus presence of AF. On multivariable logistic regression, AF (prevalent and incident AF combined; P=0.049), infarct volume (P=0.017), preadmission mRS score (P<0.001), and admission NIHSS score (P<0.001) were independently associated with an unfavorable 90-day outcome (Table 2) . We then repeated the analyses separately entering prevalent AF and incident AF as dichotomized variables. In these analyses, only incident AF (odds ratio, 1.44; 95% confidence interval, 1.01-2.05; P=0.046), but not prevalent AF (odds ratio, 2.46; 95% confidence interval, 0.91-6.65; P=0.076), was independently associated with an unfavorable 90-day outcome.
Discussion
AF represents the most common serious heart rhythm problem and accounts for the majority of all CES. 4, 19 Importantly, AF-related strokes have been consistently found to portend a poor prognosis. 3, 5, 6, 9 Increasingly, it is understood that AF may be related to the mechanisms of, and prognosis from, acute ischemic stroke beyond the known links between AF and acute cerebral thromboembolism. 20 This is an important consideration because patients with AF remain at substantial risk of cerebral infarction even when appropriately treated with oral anticoagulants, the current standard of care for secondary stroke prophylaxis. 4, 7 Identifying an independent contribution of AF to an unfavorable outcome after CES would indicate the existence of AF-specific factors that negatively affect poststroke outcome. These could represent novel therapeutic targets to mitigate AF-related sequelae. Indeed, we found that among patients with CES, those with AF had significantly worse outcomes by 90 days. In line with our observation, a previous investigation reported increased mortality of patients with AF compared with patients with non-AF-related CES. 21 However, because ) and (B) admission National Institutes of Health Stroke Scale (NIHSS) score. C, In addition, AF patients had a worse 90-day modified Rankin Scale (mRS) score, as well as worse 90-day mRS score when adjusted for the baseline mRS (ie, they had more frequent worsening of the mRS from baseline to 90 days). D, There was no significant difference in the 90-day survival between patients with vs without AF (in 6 patients with and 3 patients without AF, the exact time to death could not be established and their time to death defined as 90 days). Boxes are median±interquartile range, dotted lines indicate mean, whiskers indicate 10th/90th percentile, and outliers are 5th/95th percentile. Mann-Whitney U test was used for comparisons of the CHA 2 DS 2 -VASc, NIHSS, 90-day mRS, and mRS worsening from baseline to 90 days. by guest on July 24, 2017 http://stroke.ahajournals.org/ Downloaded from previous analyses were not adjusted for potential confounders, it remained to be shown whether AF truly represents an independent risk factor for an unfavorable outcome after CES. In particular, AF is strongly associated with advancing age and other vascular comorbidities, 4, 8 which represent well-recognized risk factors for a poor poststroke outcome. 22, 23 We demonstrate that the association between AF and unfavorable outcome was independent of these and other critical determinants of the outcome after acute ischemic stroke, namely, age, sex, infarct volume, baseline functional deficit, initial deficit severity, and AF-related vascular comorbidities. 10, 22, 23 These results strengthen the hypothesis that the known link between AF and poor outcome after stroke involves events not directly related to established AF-related comorbidities or the embolic event per se-an observation that may serve as the impetus to further investigate potential underlying pathomechanisms. Nevertheless, given our retrospective research design and relatively small sample size, our results should be considered hypothesis generating only that will require confirmation in future studies.
Precisely, how AF is related to an unfavorable outcome after stroke is not well understood. It has been noted that patients with AF have lower than expected cerebral blood flow, which could contribute to impaired cerebral autoregulation and aggravate stroke severity. 9 Proposed underlying mechanisms could be related to a reduced cardiac output, cardiac remodeling, or underdeveloped cerebral collateral circulation. 9, 24, 25 Although our results are in line with previous observations that AF carries an excess risk of poor outcome independent of underlying heart disease 26 ; our study design did not enable us to conduct detailed electrographic and echocardiographic investigations to clarify this issue. Furthermore, studies on the robustness of cerebral collateral circulation among patients with large-artery infarction did not demonstrate a significant difference between patients with versus without AF. 27 Yet, in our study, the independent association of AF with the outcome remained after adjustment for both clinical (NIHSS) and imaging (infarct volume) markers of the stroke severity. Hence, it seems unlikely that reduced cerebral blood flow was a major determinant of outcome. Alternatively, AF has been associated with chronic cerebral white-matter injury, 28 which has been associated with decreased cerebral perfusion, greater stroke severity, and worse overall outcome after stroke. 10, 11, 15 The potential association between AF and chronic brain whitematter injury is of further interest because AF increases the risk of cognitive impairment independent of incident stroke. 29 Finally, AF might additionally affect stroke severity and thus poststroke outcome via concomitant or resultant endothelial dysfunction, oxidative stress, and inflammation. 4, 20, 30 Strengths of our study are related to the investigation of a well-characterized, homogenous patient population and the collection of extensive clinical information. The approach is contemporary and important and uses a robust stroke classification system that aids in minimizing rater bias by integrating multiple aspects of ischemic stroke evaluation in a probabilistic and objective manner that is increasingly used in scientific investigations relating to ischemic stroke subtypes.
14 Finally, we adjusted our analyses for key factors that have been associated with a poor poststroke outcome, including planimetrically determined infarct volumes.
Our study has several limitations. First, although our data show a strong association between AF and outcome, a causal relationship remains to be established. Second, our sample size was modest in size, and we did not have information available on prestroke cognitive performance, which could have affected outcome in patients with stroke. However, analyses were adjusted for the prestroke mRS score, assuaging concerns that our results are biased by preexisting functional deficits. Not all patients without AF underwent 30-day event monitoring, and few underwent long-term monitoring with implantable devices. Thus, we may have underestimated the incidence of (paroxysmal) AF. However, this would be expected to bias our results toward an absent difference between the groups. Hence, our analysis arguably strengthens the hypothesis that AF independently contributed to an unfavorable outcome. Although exclusion of patients with TIA may have introduced bias, this concern is assuaged by the observation that there was no difference in the presence of AF in included patients versus excluded TIA patients with presumed cardioaortic embolism. Furthermore, brain MRI was obtained at the discretion of the treating physician resulting in the exclusion of ≈23% of patients (eg, MRI was not obtained if it was not expected to alter clinical management, in the presence of contraindications, or because of patient refusal). Although this may have introduced a bias, our approach is consistent with clinical practice and thus enables better generalization of our results. In addition, restricting analyses to patients with MRI allowed for reliable exclusion of stroke mimics and rigorous adjustment for the infarct volume, which has been associated with AF and is one of the most important determinants of poststroke outcomes.
Conclusions
AF is associated with an unfavorable 90-day functional status among patients with a CES cause independent of established risk factors and stroke severity. This observation strongly suggests the presence of AF-specific factors that affect CES severity consistent with the currently developed model that posits AF as a marker of an underlying cardiovasculopathy that contributes to stroke risk in parallel to, but independent of, AF-related thromboembolism. 31 Identifying the tissue substrate of such a cardiovasculopathy may aid in the development 
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